Zobrazeno 1 - 10
of 64
pro vyhledávání: '"M, Studena"'
Autor:
E. Grey, J. Trupl, E. Kukuckova, Stanislav Spanik, M. Studena, J. Sykora, Vladimir Krcmery, A. Kunova, K. V. I. Rolston, P. Karen, K. Kralovicova, A. Demitrovicova, P. Pichna
Publikováno v:
Infectious Diseases in Clinical Practice. 7:199-202
Autor:
J. Sisolakova, Vladimir Krcmery, A. Kunova, Z. Jesenska, J. Nogova, R. Botek, J. Sufliarsky, M. Vanickova, J. Gyarfas, Stanislav Spanik, M. Studena, J. Trupl, J. Mardiak
Publikováno v:
Journal of Hospital Infection. 36:223-228
Five cases of fungaemia due to Fusarium spp. in cancer patients are described. Two were breakthrough cases, despite ongoing therapy with amphotericin B. Three were caused by Fusarium solani, one by F. oxysporum and one by F. dimerum. Four patients di
Autor:
E. Grey, Sálek T, A. Kunova, L. Drgona, J. Svec, P. Koren, J. Mardiak, J. Sufliarsky, E. Oravcova, E. Kukuckova, P. Pichna, J. Lacka, J. Trupl, M. Studena, Stanislav Spanik, Vladimir Krcmery
Publikováno v:
Journal of Medical Microbiology. 46:517-523
One hundred and twenty-three breakthrough bacteraemias (BB) were defined during a 5-year period in a National Cancer Centre, among 9986 admissions and a total of 979 bacteraemic episodes analysed. Of 123 bacteraemias in 103 patients, 77 were polymicr
Autor:
P. Pichna, S. Grausova, M. Studena, E. Grey, Vladimir Krcmery, A. Kunova, A. Demitrovicova, J. Trupl, D. Sorkovska, P. Koren, Stanislav Spanik, Z. Jesenska, I. Krupova, K. Kralovicova
Publikováno v:
Microbial Drug Resistance. 3:283-287
From 1989 until 1996, during the last 8 years, the proportion of Candida (C.) krusei, and other non-albicans Candida spp. isolated from surveillance cultures and from sterile body sites, was analyzed among 13,758 admissions in a National Cancer Insti
Autor:
E. Oravcova, A. Kunova, I. Ilavska, Vladimir Krcmery, Stanislav Spanik, P. Koren, K. Stopkova, J. Trupl, P. Pichna, I. Krupova, M. Studena, J. Lacka, S. Grausova
Publikováno v:
International Journal of Antimicrobial Agents. 7:101-107
Two hundred and fourteen episodes of polymicrobial bacteremia in 182 cancer patients in a period of 6 years in a 360-bed National Cancer Institute were analyzed for etiology, risk factors and outcome. Variables were compared with 187 episodes of mono
Autor:
M. Studena, Stanislav Spanik, J Silva, J Svec, L. Drgona, E. Grey, L. Sevcikova, J. Lacka, Vladimir Krcmery, E. Oravcova, E. Kukuckova
Publikováno v:
Infection. 24:319-323
Fifty cancer patients with funguria of10(5) CFU/ml, dysuria and leukocyturia were retrospectively analyzed for etiology, risk factors and outcome. In 72% of cases Candida albicans and in 28% non-albicans Candida spp. (Candida krusei, Candida tropical
Autor:
M. Studena, E. Kukuckova, A. Vonkomerová, Vladimir Krcmery, L. Helpianska, T. Kollár, J. Sufliarsky, J. Lacka, V. Studena, E Hlavácová, J. Trupl, P. Pichňa, Sálek T
Publikováno v:
Chemotherapy. 40:431-434
In a comparative randomized trial, teicoplanin 5 mg/kg plus either netilmicin 5 mg/kg or pefloxacine 10 mg/kg was administered in a once daily empiric therapy to 40 cancer patients with fever and neut
Publikováno v:
Drugs. 58:266-268
Autor:
K. Stopkova, P. Pichna, J. Lacka, I. Krupova, M. Studena, Vladimir Krcmery, E. Oravcova, E. Kukuckova, S. Grausova
Publikováno v:
Journal of Hospital Infection. 34:75-77
Autor:
K. Kralovicova, M. Studena-Mrazova, J. Netriova, Vladimir Krcmery, P. Koren, Stanislav Spanik, A. Demitrovicova, S. Grausova, J. Halko, J. Novotny, E. Kukuckova, I. Krupova
Publikováno v:
Journal of chemotherapy (Florence, Italy). 9(6)
The purpose of this study was to determine if patients with high vancomycin (VAN) serum levels experience more toxicity than underdosed patients with lower (VAN) levels, and whether low VAN serum levels cause therapeutic failures in patients with gra